Kodiak Sciences (KOD) Preferred Stock Liabilities (2017 - 2018)
Kodiak Sciences' (KOD) quarterly Preferred Stock Liabilities came in at $50.0 million in Q3 2018, little changed on a QoQ basis from $50.0 million in Q4 2017.
Kodiak Sciences (KOD) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
Kodiak Sciences (KOD) has 2 years of Preferred Stock Liabilities data on file, last reported at $50.0 million in Q3 2018.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $50.0 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $50.0 million (changed N/A YoY) and the FY2017 annual result came in at $50.0 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities was little changed at $50.0 million in Q3 2018, from $50.0 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $50.0 million in Q4 2017 to a low of $50.0 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 50.02 Mn |
| Dec 31, 2017 | 50.02 Mn |